Atish Choudhury, MD, PhD

Dr Choudhury shares recent updates from 2021 meetings including ASCO GU, AUA, and ESMO.

Prostate cancer experts share exciting changes to the prostate cancer treatment landscape and how we are now better equipped to take care of patients with prostate cancer.

A prostate cancer expert shares rationale for his preferences and choices while sequencing therapies in prostate cancer.

Dr Bobby Liaw talks about relationship between treatment duration, dosing and efficacy.

Dr. Atish Choudhury discusses safety features to keep in mind when choosing androgen receptor pathway inhibitors.

A prostate cancer expert shares long-term data with androgen receptor pathway inhibitors in mCSPC.

Dr. Choudhury discusses treatment considerations and treatment options for mCSPC.

Dr. Atish Choudhury provides an overview of advances and changes in management of patients with metastatic castration sensitive prostate cancer (mCSPC) in the last decade.